Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic-Reference-Cited by-同舟云学术

Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic

Published:2021-11-09 Issue:2 Volume:16 Page:204-212
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Resp Viruses

Author:

Tunheim Gro¹^ORCID,Rø Gunnar Øyvind Isaksson¹,Tran Trung²,Kran Anne‐Marte Bakken¹,Andersen Jan Terje²³,Vaage Eline Benno²,Kolderup Anette²,Vaage John Torgils²,Lund‐Johansen Fridtjof²⁴,Hungnes Olav¹

Affiliation:

1. Division of Infection Control Norwegian Institute of Public Health Oslo Norway

2. Department of Immunology Oslo University Hospital Rikshospitalet, University of Oslo Oslo Norway

3. Department of Pharmacology, Institute of Clinical Medicine University of Oslo Oslo Norway

4. ImmunoLingo Convergence Centre University of Oslo Oslo Norway

Funder

Helse Sør-Øst RHF

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/irv.12932

Reference34 articles.

1. World Health Organization (WHO).Timeline of WHO's response to COVID‐19.2020.https://www.who.int/news/item/29-06-2020-covidtimeline. Accessed 13.12.20.

2. Folkehelseinstituttet.Ukerapport—uke 9.https://www.fhi.no: Folkehelseinstituttet; 10.03.21 2021.

3. Folkehelseinstituttet.Ukerapport—uke 18.https://www.fhi.no: Folkehelseinstituttet; tirsdag 19. mai 2020 2020.

4. The COVID-19 pandemic in Norway: The dominance of social implications in framing the policy response

5. Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults;BMC Infectious Diseases;2024-08-20

2. Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada;Canadian Medical Association Journal;2023-10-29

3. Modeling geographic vaccination strategies for COVID-19 in Norway;2023-08-21

4. Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands;Influenza and Other Respiratory Viruses;2023-08

5. Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers;Frontiers in Public Health;2023-07-21